A3914 / Ipsen - LARVOL DELTA

A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs. (PubMed, J Oncol) - "Then, a predictive signature based on the expression of 13 m6A-lncRNAs was constructed by the Lasso regression algorithm, including UBA6-AS1, AC139149.1, U91328.1, AC138207.5, AC025171.4, AC008760.1, ITGB1-DT, AP001619.1, AL391422.4, AC104532.2, ZEB1-AS1, AC156455.1, and AC104819.3...In summary, we have identified some m6A-lncRNAs that correlated with prognosis and tumor immune microenvironment in COAD. In addition, a potential alternative signature based on the expression of m6A-lncRNAs was provided for the management of COAD patients."

Journal • Colon Cancer • Colorectal Adenocarcinoma • Gastrointestinal Cancer • Oncology • ITGB1-DT • ZEB1

Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. (PubMed, J Transl Med) - "The current study provides novel insights into the lncRNA-related ceRNA network in BC and the 4 lncRNA biomarkers may be independent prognostic signatures in predicting the survival of BC patients."

Biomarker • Journal